Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

McKesson Corp (NY:MCK)

786.00 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about McKesson Corp

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
22 23 Next >
McKesson Corporation Reports Fiscal 2024 Fourth Quarter and Full Year Results
From McKesson Corporation
Via Business Wire
How To Earn $500 A Month From McKesson Stock Ahead Of Q4 Earnings Report
McKesson offers a quarterly dividend amount of 62 cents per share. How can investors pocket a regular $500 monthly? 
Via Benzinga
Investor Optimism Decreases Slightly, But Dow Records Gains For 4th Day
 
Via Benzinga
Topics Stocks
Disney, Electronic Arts And 3 Stocks To Watch Heading Into Tuesday
 
Via Benzinga
Here's How Much $1000 Invested In McKesson 20 Years Ago Would Be Worth Today
 
Via Benzinga
How Is The Market Feeling About McKesson?
 
Via Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have $500 Today
 
Via Benzinga
McKesson Corp. (NYSE: MCK) is a Leading Gainer in Wednesday Morning Trading
Via Investor Brand Network
Topics Economy
Forget Individual Consumer Stocks: Buy This ETF Instead
Here's an ETF that outperforms the S&P 500 over a longer time horizon. 
Via The Motley Fool
Topics ETFs Stocks
McKinsey Faces Criminal Probe By DOJ For Opioid Consulting: Report
The U.S. Department of Justice is conducting a criminal investigation into the consulting firm McKinsey & Company for its role in advising major opioid manufacturers on increasing sales. The... 
Via Benzinga
McKesson Corporation Declares Quarterly Dividend
From McKesson Corporation
Via Business Wire
The Top 3 Healthcare Stocks to Buy in April 2024
These are strong buy stocks within the healthcare industry that investors should watch in 2024 due to their strong returns. 
Via InvestorPlace
Jim Cramer Is 'Willing To Let This Pharma Stock Catch Fire,' Advises Not To Sell McKesson
The "Mad Money" host recommended buying some Marvell Technology, and then wait until under $60 to buy the rest. 
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,200 Today
 
Via Benzinga
Peering Into McKesson's Recent Short Interest
 
Via Benzinga
McKesson Corp. (NYSE: MCK) Making Surprising Moves in Tuesday Session
Via Investor Brand Network
Topics Economy
Top Stock Reports For Apple, Nvidia & Eli Lilly
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc., NVIDIA Corporation, and Eli Lilly and Company. 
Via Talk Markets
McKesson Corporation Announces Fourth Quarter Fiscal 2024 Earnings Release Date
From McKesson Corporation
Via Business Wire
Rite Aid Forges Path To Financial Recovery With Major Settlement: Report
Rite Aid (OTC: RADCQ) settles with lenders and DOJ, marking a crucial step toward bankruptcy resolution by April, Reuters reports. Attorney Aparna Yenamandra highlights broad stakeholder agreement,... 
Via Benzinga
Topics Bankruptcy
$100 Invested In This Stock 5 Years Ago Would Be Worth $400 Today
 
Via Benzinga
How Is The Market Feeling About McKesson?
 
Via Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $13,000 Today
 
Via Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,900 Today
 
Via Benzinga
Which Stocks Will Dominate The Future Of Tech? UBS Shares Its Top Picks In AI, Healthtech, Greentech, And Fintech
In a recent report, global wealth manager UBS has identified the sectors that are likely to drive the next wave of technological innovation and the stocks that stand to benefit. 
Via Benzinga
Topics Artificial Intelligence
McKesson Corp. (NYSE: MCK) Sets New 52-Week High in Monday Session
Via Investor Brand Network
Topics Economy
US Federal Trade Commission Investigates Drug Shortages Amid Allegations Of Market Manipulation
FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scrutiny. Industry defends practices. 
Via Benzinga
3 Attractive Medical Stocks To Buy After Earnings
Quite a few top-rated stocks have highlighted this week’s earnings lineup with now appearing to be an ideal time to buy. Following their favorable quarterly results, here are 3 intriguing healthcare... 
Via Talk Markets
Medical Supplies-Focused McKesson Shares Fall On Q3 Earnings Performance, Analyst Says Street 'Wanted More'
McKesson beats expectations with Q3 2024 sales of $80.9 billion, up 15%. U.S. Pharmaceutical Segment thrives, adjusted EPS at $7.74, exceeding consensus. 
Via Benzinga
McKesson (MCK) Q3 2024 Earnings Call Transcript
MCK earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
McKesson Corporation Reports Fiscal 2024 Third Quarter Results and Raises Full Year Guidance
From McKesson Corporation
Via Business Wire
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.